Astera Labs, Inc. (NASDAQ:ALAB) Stock Has Consensus Target Price of $340.79

Astera Labs, Inc. (NASDAQ:ALAB) has been given an average rating of “Moderate Buy” by the twenty-two research firms that are currently covering the company, Marketbeat.com reports. Eleven analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $340.79.

Several research firms have recently commented on ALAB. Roth Capital reissued a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Barclays lifted their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Friday, October 9th. Morgan Stanley boosted their price target on shares of Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Finally, Royal Bank Of Canada increased their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This trade represents a 7.49% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is currently owned by company insiders.

Institutional Trading of Astera Labs

A number of institutional investors have recently bought and sold shares of the business. Chicago Partners Investment Group LLC grew its holdings in Astera Labs by 18.1% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 2,253 shares of the company’s stock valued at $579,000 after buying an additional 345 shares during the last quarter. Rakuten Investment Management Inc. grew its holdings in Astera Labs by 17.0% in the third quarter. Rakuten Investment Management Inc. now owns 50,571 shares of the company’s stock valued at $18,096,000 after purchasing an additional 7,333 shares during the period. Aware Super Pty Ltd as trustee of Aware Super increased its stake in Astera Labs by 49.7% during the third quarter. Aware Super Pty Ltd as trustee of Aware Super now owns 19,688 shares of the company’s stock worth $7,008,000 after acquiring an additional 6,532 shares during the last quarter. BOCHK Asset Management Ltd increased its position in shares of Astera Labs by 192.7% in the third quarter. BOCHK Asset Management Ltd now owns 20,050 shares of the company’s stock worth $7,137,000 after acquiring an additional 13,200 shares in the last quarter. Finally, Signature Equity Partners LLC raised its holdings in shares of Astera Labs by 1,680.0% during the 3rd quarter. Signature Equity Partners LLC now owns 89 shares of the company’s stock valued at $32,000 after buying an additional 84 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

NASDAQ ALAB opened at $258.70 on Tuesday. The stock has a market capitalization of $44.88 billion, a P/E ratio of 128.07 and a beta of 3.68. The firm’s 50-day moving average is $308.12 and its two-hundred day moving average is $254.98. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period last year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts anticipate that Astera Labs will post 2.71 EPS for the current year.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.